Management of Depression and Low Appetite in Elderly Patients

Primary Recommendations

The American Academy of Family Physicians recommends mirtazapine as a first-line agent for elderly patients with depression and poor appetite, combining antidepressant efficacy with appetite-stimulating properties 1, 2
Mirtazapine at 7.5-30 mg at bedtime promotes sleep, appetite, and weight gain in elderly patients with depression, making it ideal for this clinical scenario 3, 4
Retrospective data shows mirtazapine 30 mg daily resulted in mean weight gain of 1.9 kg at three months and 2.1 kg at six months, with approximately 80% of patients experiencing weight gain 4

The American Family Physician recommends tapering citalopram over 10-14 days to limit withdrawal symptoms, such as headache, irritability, dizziness, and electric shock-like sensations 3
Start mirtazapine at 7.5 mg at bedtime during the citalopram taper, as there is no significant drug interaction between these medications 3, 4
Titrate mirtazapine to 15-30 mg at bedtime based on response and tolerability over 2-4 weeks 3, 4

Megestrol acetate 400-800 mg/day improves appetite in approximately 25% of patients, though it carries risks of fluid retention and thromboembolic events in elderly patients 2, 5
Dexamethasone 2-8 mg/day offers faster onset but should be reserved for shorter life expectancy due to significant side effects, such as hyperglycemia, muscle wasting, and immunosuppression, with prolonged use 2, 5
Sertraline 25-50 mg daily is well-tolerated in elderly patients and has less effect on drug metabolism than other SSRIs, making it suitable if multiple medications are present 1
Escitalopram 5-10 mg daily is effective for comorbid depression and anxiety in elderly patients, though it does not address appetite 1
Avoid paroxetine due to significant anticholinergic effects in elderly patients 1
Avoid fluoxetine due to greater risk of agitation and overstimulation in this age group 1

Screen for malnutrition using validated tools, as depression is strongly associated with malnutrition in elderly patients 6, 7
Provide oral nutritional supplements when food intake is 50-75% of usual intake to prevent further nutritional decline 4, 5
Offer small, frequent meals with energy-dense foods and protein-enriched options to maximize nutritional intake without increasing meal volume 2, 4
Arrange meals at a dining table with others rather than isolated eating to promote social interaction and improve intake 5
Ensure adequate feeding assistance and emotional support during meals if functional limitations are present 4, 5
Consider referral to dietician for individualized nutritional counseling 8

Monitor for excessive sedation, particularly in the first 1-2 weeks, as this is the most common side effect in elderly patients 3
Assess for weight gain and appetite improvement within 1-2 weeks of starting mirtazapine 3, 4
Schedule follow-up at weeks 1, 2, 4, 8, and 12 to monitor efficacy, tolerability, and weight changes 8, 2
Continue antidepressant treatment for 4-12 months after first episode of major depression to prevent relapse 1
Consider prolonged treatment if this represents recurrent depression, as relapse risk increases to 70% after two episodes 1

The American Academy of Family Physicians and other guideline societies recommend that nutritional supplements should not be routinely recommended for elderly patients with anxiety and depression unless they are malnourished or at risk of malnutrition 9, 10
Depression is strongly associated with malnutrition and weight loss in elderly patients, and all depressed older patients must be screened for malnutrition using validated tools 9, 10

The American Geriatrics Society suggests that high-energy oral nutritional supplements may improve depressive symptoms when malnutrition is present, particularly in hospitalized elderly patients 10
Vitamin D supplementation may provide benefit specifically for elderly patients with documented vitamin D deficiency, although evidence is limited to one trial in a specific population (prediabetes) 11
Omega-3 fatty acids show mixed results and should not be routinely recommended due to heterogeneous results and lack of benefit in patients with comorbid anxiety 11, 12

The American Academy of Family Physicians recommends mirtazapine as first-line for elderly patients with depression and poor appetite, combining antidepressant efficacy with appetite-stimulating properties 11, 12
Nutritional supplements are adjunctive to, not replacements for, evidence-based psychiatric treatment, and dehydration is a common precipitating factor for both delirium and depression in hospitalized elderly 9, 10

No trial has used cure of depression as an outcome measure for nutritional interventions in older persons, and the minimum clinically significant difference has not been defined for the Geriatric Depression Scale used in most nutrition trials 9, 10
Depression treatment with medications takes time to be effective, so enteral nutrition may be needed during the early phase of severe anorexia to prevent undernutrition 11, 12